Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Study of Short Course (One-week) Radiation Therapy Versus Standard Course (Three-week) Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme

NCT01450449 is registered in ClinicalTrials.gov with International Atomic Energy Agency as lead sponsor.

NCT NCT01450449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01450449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Study of Short Course (One-week) Radiation Therapy Versus Standard Course (Three-week) Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme
Lead sponsor
International Atomic Energy Agency
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2009
Completion date
November 30, 2014
Enrollment
115 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme